Insider Buying: Vivani Medical, Inc. (NASDAQ:VANI) Director Acquires $4,999,998.78 in Stock

Vivani Medical, Inc. (NASDAQ:VANI) Director Gregg Williams acquired 3,968,253 shares of the stock in a transaction that occurred on Friday, November 8th. The stock was acquired at an average cost of $1.26 per share, with a total value of $4,999,998.78. Following the completion of the purchase, the director now owns 4,695,861 shares of the company’s stock, valued at $5,916,784.86. This trade represents a 545.38 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Vivani Medical Price Performance

NASDAQ:VANI opened at $1.31 on Friday. Vivani Medical, Inc. has a 1-year low of $0.84 and a 1-year high of $7.80. The company has a 50-day moving average of $1.23 and a 200 day moving average of $1.36. The firm has a market cap of $72.39 million, a PE ratio of -2.91 and a beta of 3.20.

Vivani Medical (NASDAQ:VANI) last released its quarterly earnings data on Tuesday, August 13th. The company reported ($0.10) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.12) by $0.02.

Analyst Ratings Changes

Separately, HC Wainwright assumed coverage on shares of Vivani Medical in a research note on Thursday, November 7th. They issued a “buy” rating and a $3.00 price objective for the company.

About Vivani Medical

Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.